Original paper
Prognostic role of vascular endothelial growth factor and hypoxia inducible factor in HCC patients after conventional and DEB-mediated chemoembolization
Abstract
Introduction/aims: Transcatheter arterial chemoembolization (TACE) is the conventional treatment for the BCLC “intermediate” stage HCC. TACE treatment prompts a neo-angiogenic reaction to ischemia that probably affects its impact. Our study sought significant differences, if any, in the levels of two circulating markers of neo-angiogenesis, Vascular Endothelial Growth Factor (VEGF) and Hypoxia-Inducible Factor (HIF), after conventional TACE...
Paper Details
Title
Prognostic role of vascular endothelial growth factor and hypoxia inducible factor in HCC patients after conventional and DEB-mediated chemoembolization
Published Date
Feb 1, 2017
Journal
Volume
49
Issue
1
Pages
e35 - e35
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History